About 200 reports

  • Dementia
  • DEMENTIA

About Dementia and Movement Disorder Treatment Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and...

  • Dementia
  • Allergan plc
  • Eisai Co., Ltd.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Global Dementia Disease Market Size , By
  • Global Dementia Disease Market Size , By

Executive Summary Progressive numbers of neurological disorders along with escalating demand for drugs to control of Alzheimer Disease. The Global Alzheimer’s Market is growing at a moderate rate over last five years on account of rising expenditure on health care especially neurological disorders among ageing population...

  • Dementia
  • Axovant Sciences Ltd.
  • Biotie Therapies Corp.
  • Novartis AG
  • Pfizer Inc.

Vascular Dementia - Epidemiology Forecast to 2027 ##.

  • Dementia
  • France
  • Germany
  • Italy
  • Spain

Drug A: Company ## ##. ##. ##.

  • Dementia
  • Mental Health
  • United States
  • Market Shares
  • SUB-TYPE OF CO-MORBID DEMENTIA, TOTAL (000S)
  • USA PREVALENCE OF LEWY BODY DEMENTIA BY 5-YR AGE COHORT, FEMALES (000S)

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Lewy Body Dementia in 12 Major Markets Dementia with Lewy Bodies (DLB) is the second most frequent cause of age related neurodegenerative dementia, accounting for approximately a third of all dementias. The presence of Lewy bodies in the brain is linked to low levels of...

  • Dementia
  • United States
  • Forecast
  • FEATURES OF VASCULAR DEMENTIA PATIENTS
  • Prevalence of Vascular Dementia, total (000s)

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Vascular Dementia in 13 Major Markets Vascular Dementia (VaD) is the second most common form of dementia after Alzheimer disease. It is also known as multi-infarct dementia (MID) and vascular cognitive impairment (VCI), and is caused by issues with blood supply...

  • Dementia
  • Mental Health
  • Pathology
  • East Asia
  • Alzheimer's disease in 2016, and the patients diagnosed with Alzheimer's or another dementia
  • Alzheimer's and other dementias, including blood vessel damage and genetic risk

Alzheimer’s disease is the most common cause of dementia among older people. It is a devastating condition for those afflicted as well as their family members and caregivers; the situation is only getting worse as the population ages. With the ageing global population, the number of patients suffering from Alzheimer’s disease is predicted...

  • Dementia
  • World
  • Biogen Idec Inc.
  • Eisai Co., Ltd.
  • Roche Group
  • Eating Problems
  • 4.3 SYMPTOMS

Amyotrophic Lateral Sclerosis: Opportunity Analysis and Forecast to 2027 Summary Amyotrophic Lateral Sclerosis (ALS) drug sales in 2017 were approximately $187M across the seven major markets - the US, 5EU (France, Germany, Italy, Spain and the UK), and Japan. Over the 10-year forecast period, the...

  • Dementia
  • Therapy
  • United States
  • Forecast
  • Ionis Pharmaceuticals, Inc.
  • DSM-IV Criteria for the Diagnosis of Dementia
  • 4.1 BIBLIOGRAPHY

EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2026 Summary Alzheimer’s disease (AD) is a subtype of dementia and is an irreversible, neurodegenerative brain disease of the elderly, characterized by the death of brain cells, which leads to a progressive decline in memory and cognitive...

  • Dementia
  • Spain
  • United States
  • World
  • Forecast

Cognition and Memory Enhancement Drugs: Technologies and Global Markets Chapter ## Introduction Study Goals and Objectives Reasons for Doing This Study Scope of Report Information Sources and Methodology Intended Audience Geographic Breakdown Analyst’s Credentials Related BCC Research Report

  • Dementia
  • Mental Health
  • World
  • JAN 09, 2018: LARGE-SCALE PROTEIN ANALYSIS CAN PROVIDE NEW POSSIBILITIES FOR DIAGNOSIS AND TREATMENT IN DEMENTIA
  • OCT 09, 2017: KAROLINSKA INSTITUTET: SAFE TO TREAT DEMENTIA PATIENTS WITH CLOT-BUSTING DRUGS

Summary Karolinska Institutet (KI) is a medical university that offers education services.The university provides education and research in the fields of medicine and health sciences. Its education courses include audiology, biomedicine, biomedical lab science, dental hygiene, medicine, nursing, occupational therapy...

  • Cancer
  • Dementia
  • Sweden
  • Karolinska Institutet Holding
  • Takeda Pharmaceutical Company Limited

GLOBAL ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST 2018-2026 ##.

  • Dementia
  • Therapy
  • World
  • Key Clinical Trial Landscape Updates
  • KEY EVENTS AFFECTING THE AD COMPETITIVE LANDSCAPE (JUNE 2018-JULY 2018)

Alzheimer’s Disease: Dynamic Market Forecast to 2026 Summary "Alzheimer’s Disease: Dynamic Market Forecast to 2026", research report is designed to help clients stay abreast of the latest news in the Alzheimer’s Disease (AD) space, including regulatory, commercial, and clinical events as well as...

  • Dementia
  • United States
  • Eisai Co., Ltd.
  • Novartis AG
  • Roche Group
  • EXELON
  • EISAI PHARMACEUTICALS

You can easily book an appointment with one online.

  • Dementia
  • Forecast
  • Allergan plc
  • Eisai Co., Ltd.
  • Novartis AG
  • 6.1.1 PROBABLE AD DEMENTIA
  • DSM-IV CRITERIA FOR THE DIAGNOSIS OF DEMENTIA

PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2026 Summary Alzheimer’s disease (AD) is a looming endangerment to global health, and a threat to the world economy. One in every three seniors in the US dies with AD or another form of dementia. It is the sixth leading...

  • Dementia
  • Allergan plc
  • Biogen Idec Inc.
  • Eisai Co., Ltd.
  • Novartis AG

Global Alzheimer’s Disease Therapeutics and Diagnostics Market 2018-2028 ##.

  • Dementia
  • Diagnostics
  • Mental Health
  • World
  • Market Size
  • May 21, 2018: Sheffield scientists get £150K boost for pioneering dementia research
  • May 21, 2018: Our scientists receive £150,000 boost for pioneering dementia research

Summary University of Sheffield (Sheffield University) is an educational service provider that offers undergraduate, postgraduate, research and certificate programmes.The university offers courses in various fields including arts and humanities, engineering, medicine, dentistry and health; social sciences. It also...

  • Dementia
  • Healthcare
  • Pharmaceutical
  • Therapy
  • United Kingdom
  • NEURODEGENERATIVE DISORDERS THERAPEUTICS MARKET, COMORBIDITIES ASSOCIATED WITH
  • NEURODEGENERATIVE DISORDERS THERAPEUTICS MARKET, SYMPTOMS OF AD, PD, HD, ALS

Alzheimer' s & Dementia; ##(##): ##-## Inglese M (2006).

  • Dementia
  • World
  • Biogen Idec Inc.
  • Novartis AG
  • Roche Group
  • Nov 16, 2017: Researchers identify first brain training exercise positively linked to dementia prevention
  • Aug 14, 2017: Brain Scan Study Adds to Evidence That Lower Brain Serotonin Levels are Linked to Dementia

Summary National Institute on Aging (NIA), a subsidiary of National Institutes of Health is a healthcare institute that offers health and aging care services.The institute conducts research on aging through researchers and the international community of scientists. Its services comprise research, extramural program,...

  • Dementia
  • Healthcare
  • Pain Relief
  • Pharmaceutical
  • United States
  • 2.1 Global Dementia Market
  • 1.1 Definition of Dementia

Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such...

  • Dementia
  • Eli Lilly & Co.
  • Novartis AG
  • Pfizer Inc.
  • Roche Group

According to Alzheimer’s Association, one in every ## adults in the United States dies with Alzheimer’s or another dementia.

  • Dementia
  • Mental Health
  • Therapy
  • North America
  • Market Size

EUROPE ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST 2018-2026 ##.

  • Dementia
  • Mental Health
  • Therapy
  • Europe
  • Market Size
  • 10.1.4 Types of Dementia
  • Untitled

About neurodegenerative diseases According to the EU JPND, neurodegenerative diseases refer to conditions that involve the neurons in the brain. These conditions can affect balance, movement, speech, and respiratory and cardiac functions. They can be inherited or be of unknown etiology. Neurodegenerative diseases are incurable and are severely...

  • Dementia
  • Biogen Idec Inc.
  • Merck Serono S.A.
  • Novartis AG
  • Pfizer Inc.

Dementia is one of the major causes of disability among the elderly population.

  • Dementia
  • Therapy
  • United States
  • World
  • Company Financials
  • Nicergoline Major Producer and Their Market Share
  • Rivastigmine

This study focuses on China’s Alzheimer Disease Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s...

  • Dementia
  • China
  • Trade
  • Janssen Biotech, Inc.
  • Xian-Janssen Pharmaceutical Ltd.
  • DISEASE OVERVIEW

AD is a subtype of dementia, and accounts for approximately ##% of the total dementia cases worldwide.

  • Dementia
  • Allergan plc
  • Eisai Co., Ltd.
  • Novartis AG
  • Roche Group

ASIA PACIFIC ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST 2018-2026 ##.

  • Dementia
  • Therapy
  • APAC
  • Market Size
  • Nicergoline Major Producer and Their Market Share
  • Overview

China’s demand for Alzheimer Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer...

  • Dementia
  • China
  • Demand
  • Guizhou Yibai Pharmaceutical Co., Ltd.
  • Kunming Longjin Pharmaceutical Co Ltd
  • MARKET DRIVERS

AD is one of the most common types of NDDs.

  • Dementia
  • Eli Lilly & Co.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • CAUSE OF THE DISEASE
  • INTRODUCTION

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Alzheimer’s disease in 12 Major Markets Alzheimer’s disease (AD) is a progressive, irreversible neurodegenerative disorder. It is the leading cause of dementia. Alzheimer’s is associated with the increase of beta amyloid and tau proteins in the brains of affected patients....

  • Dementia
  • Mental Health
  • Pathology